ZS
Zachariah Serber
Director

Zachariah Serber insider trades: Zymergen (ZY) stock sales

Director, Zymergen Last trade Sep 2, 2022 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2022
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Zachariah reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 2, 2022ZY↓ Sell$7K
Aug 11, 2022ZY↓ Sell$21K
Aug 2, 2022ZY↓ Sell$8K
Jul 5, 2022ZY↓ Sell$4K
Jun 2, 2022ZY↓ Sell$5K
May 2, 2022ZY↓ Sell$6K
Feb 28, 2022ZY↓ Sell$37K
Feb 22, 2022ZY↓ Sell$6K
Feb 14, 2022ZY↓ Sell$22K
Feb 7, 2022ZY↓ Sell$24K
Jan 31, 2022ZY↓ Sell$27K
Jan 24, 2022ZY↓ Sell$103K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Zachariah Serber's insider trades

Zachariah Serber is a director at Zymergen (ZY). Since Jan 24, 2022, Zachariah has reported no open-market purchases and 12 sales worth $269K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares returned to the company (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.